A chip developed at CERN would allow color and 3D X-rays

Modern medicine has a large number of devices to be able to see in the human body. X-rays have been the starting point in the development of such technologies as axial tomography, which allows us to see 3D images of organs inside the body. Through a series of algorithms, the X-ray images taken in the tomograph eventually generate a 3D image of what we want to observe. However, these images are still black and white and doctors often need to rely on their skills and experience to understand what the plaques show.

Ghost cars? A new viral video and its explanation

Now, a New Zealand company has developed a bio-image scanner capable of producing 3D and color images of bone, lipid and soft tissue, all thanks to to a chip developed in CERN for the use of the Large Hadron Collider.

Mars Bioimaging, The company behind this new scanner describes this as the skip that was made from black color photographs and White. This new technology called "Spectral CT" allows the sensor to measure the attenuation of specific X-ray wavelengths as they pass through different materials, bones, fats, tissues, and so on. The generated data is executed through specific algorithms, then a 3D image is generated that clearly shows the muscles, bones, water, fat, markers of the disease, and so on. The final result is frankly remarkable.

The heart of the CT Spectra scanner is the Medipix3 chip. This device, which detects and counts each individual particle that strikes the sensor, was initially developed at CERN to track particles passing through the large hadron collider. Come on, this is an interesting by-product of the research that is being done on this expensive toy that is in Switzerland.

A small version of the device has been tested see how you can diagnose bone health, for example, or find a cancer, or can -be, see specific markers as a product of vascular diseases. Until now the result is very promising.

"In all studies, the early results are promising and it is suggested that when spectral images are used regularly in the clinic, this will allow more accurate diagnosis and personalization of treatments." Said Anthony Butler, l & # 39, one of the creators of this 3D scanner

The first clinical trials will begin in the following months in New Zealand, and will be tested on patients in the departments of orthopedics and rheumatology